Acute flaccid paralysis in children is a medical emergency that can progress to respiratory failure within hours or days, ...

A new study indicates that COVID-19 is associated with an elevated risk of a rare disorder, Guillain-Barré syndrome, within six weeks after infection with the virus.

Guillain-Barre syndrome is a rare but serious condition which needs urgent treatment in hospital to prevent it progressing.

The Food and Drug Administration has flagged Guillain-Barre syndrome, a rare neurological condition, as a potential risk for Pfizer’s RSV vaccine.

Can predictive factors be identified which could aid in determining the prognosis of Guillain-Barre syndrome?

Guillain-Barré Syndrome (GBS) majorly impacts people of all ages, but it is more commonly seen in children, adults, and older age groups.

Having a COVID-19 infection is associated with an increased risk of developing the rare disorder called Guillain-Barré syndrome within the next six weeks, according to a study published in ...

New research shows COVID-19 raises the risk of Guillain-Barré syndrome more than vaccines. mRNA vaccines pose no increased risk, global data reveals.

The Food and Drug Administration has flagged Guillain-Barre syndrome, a rare neurological condition, as a potential risk for Pfizer’s respiratory syncytial virus vaccine. Two people in their 60s ...

The labeling for Abrysvo and Arexvy has been updated to include a warning regarding Guillain-Barré syndrome.

Peru’s health ministry said on Thursday that Corinthians are not at risk of contracting Guillain-Barre syndrome when they visit the country next week after the coach of the Brazilian team voiced ...

Guillain-Barré Syndrome: Natural History and Prognostic Factors A Retrospective Review of 106 Cases Inés González-Suárez; Irene Sanz-Gallego; Francisco Javier Rodríguez de Rivera; Javier Arpa ...